Table 3.
PLD (30 patients) | Other therapy (No PLD) 25 patients | |
---|---|---|
Platinum sensitive |
9 (30 %) |
8 (32%) |
Partially-platinum sensitive |
10 (33%) |
5 (20%) |
Platinum refractory | 11 (37 %) | 12 (48%) |
PLD (30 patients) | Other therapy (No PLD) 25 patients | |
---|---|---|
Platinum sensitive |
9 (30 %) |
8 (32%) |
Partially-platinum sensitive |
10 (33%) |
5 (20%) |
Platinum refractory | 11 (37 %) | 12 (48%) |